|
|
|
|
|
26.
19869 Accesses
|
Complement and systemic lupus erythematosus
Mark J Walport Arthritis Res 2002, 4(Suppl 3):S279-S293 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
27.
19437 Accesses
|
Mesenchymal precursor cells in the blood of normal individuals
Nathan J Zvaifler, Lilla Marinova-Mutafchieva, Gill Adams, Christopher J Edwards, Jill Moss, Jan A Burger, Ravinder N Maini Arthritis Res 2000, 2:477-488 (31 August 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
28.
19148 Accesses
|
What is MRI bone oedema in rheumatoid arthritis and why does it matter?
Fiona M McQueen, Benedikt Ostendorf Arthritis Research & Therapy 2006, 8:222 (5 December 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
29.
18998 Accesses
|
Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
Marcel Flendrie, Wynand HPM Vissers, Marjonne CW Creemers, Elke MGJ de Jong, Peter CM van de Kerkhof, Piet LCM van Riel Arthritis Research & Therapy 2005, 7:R666-R676 (4 April 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
TNF-α blocking therapies have shown considerable success in moderating disease activity in rheumatic diseases, however a recent study has shown that in 25% of patients, their prescription results in dermatological conditions, including eczema and skin infections.
|
|
|
30.
18425 Accesses
|
Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology
Sally Roberts, Iain W McCall, Alan J Darby, Janis Menage, Helena Evans, Paul E Harrison, James B Richardson Arthritis Res Ther 2003, 5:R60-R73 (13 November 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
31.
18395 Accesses
|
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Erik R Vossenaar, Normand Després, Elvy Lapointe, Annemarie van der Heijden, Maximillian Lora, Tatsuo Senshu, Walther J van Venrooij, Henri A Ménard Arthritis Res Ther 2004, 6:R142-R150 (5 February 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
32.
18326 Accesses
|
Molecular action of methotrexate in inflammatory diseases
Edwin SL Chan, Bruce N Cronstein Arthritis Res 2002, 4:266-273 (19 March 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
33.
18233 Accesses
|
HLA-B27: natural function and pathogenic role in spondyloarthritis
Andrew McMichael, Paul Bowness Arthritis Res 2002, 4(Suppl 3):S153-S158 (9 May 2002)
Abstract | Full text | PDF
| PubMed
|
|
|
34.
18039 Accesses
|
Arthritis and pain. Future targets to control osteoarthritis pain
Andy Dray, Simon J Read Arthritis Research & Therapy 2007, 9:212 (30 May 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
35.
17681 Accesses
|
Articular cartilage and changes in Arthritis: Collagen of articular cartilage
David Eyre Arthritis Res 2002, 4:30-35 (5 October 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
36.
17569 Accesses
|
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case–control study
Berit Sverdrup, Henrik Källberg, Camilla Bengtsson, Ingvar Lundberg, Leonid Padyukov, Lars Alfredsson, Lars Klareskog, the Epidemiological Investigation of Rheumatoid Arthritis study group Arthritis Research & Therapy 2005, 7:R1296-R1303 (23 September 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A population based case-controlled study has found that occupational exposure to mineral oils, in particular hydraulic or motor oil, increases the risk of developing rheumatoid arthritis by 30%.
|
|
|
37.
17539 Accesses
|
Arthritis and pain. Current approaches in the treatment of arthritic pain
Bruce L Kidd, Richard M Langford, Theresa Wodehouse Arthritis Research & Therapy 2007, 9:214 (11 June 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
38.
17440 Accesses
|
Tissue engineering: chondrocytes and cartilage
Tim Hardingham, Simon Tew, Alan Murdoch Arthritis Res 2002, 4(Suppl 3):S63-S68 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
39.
17399 Accesses
|
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors
Matthew P Vincenti, Constance E Brinckerhoff Arthritis Res 2002, 4:157-164 (23 November 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
40.
17343 Accesses
|
The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma
Rick Brouwer, Ger JM Pruijn, Walther J van Venrooij Arthritis Res 2001, 3:102-106 (20 December 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
41.
17053 Accesses
|
Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
R Westhovens, P van Riel, J Sibilia, G Vratsanos, I Nuamah, JC Becker Arthritis Res Ther 2004, 6(Suppl 1):86 (24 February 2004)
Full text | PDF
|
|
|
42.
17006 Accesses
|
Human Th17 cells
Sergio Romagnani Arthritis Research & Therapy 2008, 10:206 (18 April 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
43.
16709 Accesses
|
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
R Andrew Moore, Sheena Derry, Henry J McQuay, John Paling Arthritis Research & Therapy 2008, 10:R20 (7 February 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
44.
16673 Accesses
|
Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure
Theresa Kapral, Tanja Stamm, Klaus P Machold, Karin Montag, Josef S Smolen, Daniel Aletaha Arthritis Research & Therapy 2006, 8:R46 (24 February 2006)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Administering a second course of methotrexate to rheumatoid arthritis sufferers proved beneficial in nearly half of the patients studied, for whom a previous treatment with the drug was ineffective.
|
|
|
45.
16575 Accesses
|
Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis
Masaaki Takahashi, Kenichi Naito, Masashi Abe, Tomokazu Sawada, Akira Nagano Arthritis Res Ther 2004, 6:R208-R212 (12 March 2004)
Abstract | Full text | PDF
| PubMed
|
|
|
46.
16253 Accesses
|
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis
Patrick H Dessein, Anne E Stanwix, Barry I Joffe Arthritis Res 2002, 4:R5 (19 June 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
47.
16208 Accesses
|
Biology and therapy of fibromyalgia. New therapies in fibromyalgia
Lesley M Arnold Arthritis Research & Therapy 2006, 8:212 (1 June 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
48.
16110 Accesses
|
Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches
Juergen Braun, Joachim Sieper Arthritis Res 2002, 4:307-321 (6 August 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
49.
16032 Accesses
|
The vasculature and its role in the damaged and healing tendon
Steven A Fenwick, Brian L Hazleman, Graham P Riley Arthritis Res 2002, 4:252-260 (13 February 2002)
Abstract | Full text | PDF
| PubMed
|
|
|
50.
15930 Accesses
|
Activation of transforming growth factor-β1 and early atherosclerosis in systemic lupus erythematosus
Michelle Jackson, Yasmeen Ahmad, Ian N Bruce, Beatrice Coupes, Paul EC Brenchley Arthritis Research & Therapy 2006, 8:R81 (28 April 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Low efficiency of activation of transforming growth factor beta-1 is associated with increased risk of cardiovascular disease and may modulate development of atherosclerosis in patients with lupus.
|